Employees: 11-50
Total raised: $40M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.08.2022 | Series A | $40M | - |
Mentions in press and media 8
| Date | Title | Description |
| 01.08.2022 | Novasenta Closes $40M Series A Funding Round | Novasenta, a Pittsburgh, PA-based biotechnology company focused on the discovery and validation of novel targets to develop cancer therapies, raised $40M in Series A funding. The round was led by UPMC Enterprises. The company intends to use... |
| 30.07.2022 | Pittsburgh-based biotechnology firm startup Novasenta raises USD 40 million in Series A funding | Pittsburgh, July 29, 2022 — UPMC Enterprises, the innovation, venture capital, and commercialization arm of top healthcare system UPMC, sponsored the USD 40 million Series A funding for Novasenta Inc., a new biotechnology firm focused on th... |
| 29.07.2022 | Novasenta Completes $40M Series A Funding | PITTSBURGH, PA, Novasenta, a startup biotechnology company, announced the completion of $40 million in Series A financing led by UPMC Enterprises. >> Click here for more funding data on Novasenta >> To export Novasenta fundi... |
| 20.12.2021 | Pittsburgh’s biggest VC deals of 2021: Autonomy and life sciences top the list | Though final fourth quarter and year-end data on venture capital raises and other funding won’t be fully announced until the new year, Technical.ly has kept track of the money moves in Pittsburgh. With a paltry first two quarters, 2021 is l... |
| 24.08.2021 | UPMC launches cancer drug discovery company | Pittsburgh-based UPMC has launched a drug discovery and development company focused on cancer treatments. Called Novasenta, the company’s work will concentrate on the tumor microenvironment — that is, the ecosystem inside the body that surr... |
| - | Novasenta | “Home - Novasenta” |
| - | UPMC launches cancer drug discovery company | Pittsburgh-based UPMC has launched a drug discovery and development company focused on cancer treatments. Called Novasenta, the company’s work will concentrate on the tumor microenvironment — that is, the ecosystem inside the body that surr... |
| - | After Q3 2022, Pittsburgh is on track for a standout VC year | Editor’s note: These figures may vary slightly, as some deals aren’t accounted for until weeks after quarterly VC reports are published. After rebounding from its paltry venture capital deal volume in 2021 with an impressive first quarter o... |